Medpace is highlighted in a recent interview with Jim Joffrion, senior director of clinical development and operations at Athersys in Clinical Leader: A Stem Cell Company Overcomes The Challenges Of International Trials. Performing global stem cell clinical trials are complex and often present challenges. Joffrion discusses how they believe the best solution is working with a global CRO possessing experience in the countries in which the trials will be conducted.
With coverage across six continents, Medpace has the global expertise and experience to proactively plan and execute trials of all sizes. Our medical, operational, and regulatory specialists have country-specific expertise conducting trials around the world. In addition, Medpace has contributed to over 130 trials in cell and gene therapies across numerous therapeutic areas and global regions.
Read the interview to learn how Medpace fits Athersys’ criteria of selecting the right global CRO:
- Are They the Right Size?
- Find the Right Expertise
- The Importance of the Bidding Process
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.
